Oncosil Medical (ASX:OSL) is a Sydney based medical device company focused on Interventional Oncology in the pancreas and liver.
OSL’s Pancreatic Cancer Treatment Approved for Sale in Europe
May 5, 2020
OncoSil Medical (ASX:OSL) has received CE Mark approval to market and sell its breakthrough implantable radiotherapy treatment for pancreatic cancer in the EU and UK.
ASX MedTech Junior Displays Promise for Pancreatic Cancer Patients
Jan 30, 2020
OncoSil Medical (ASX: OSL) has developed a first-in-class, truly innovative device that treats unresectable locally advanced pancreatic cancer — that is, tumours that can’t be surgically removed.